The Journal of Nervous and Mental Disease
August 20, 2018
Surbhi Khanna, Lauren E. Moore, Bruce Greyson
11 citations
A 54-year-old man with bacterial meningitis experienced a complete recovery without neurological deficits despite a fluctuating Glasgow Coma Scale score between 6 and 11 during an 8-day hospitalization. He recalled an elaborate near-death experience that occurred while he was comatose. The case underscores the value of studying near-death experiences during compromised brain function to better understand consciousness.
The Journal of Nervous and Mental Disease
July 29, 2022
Mariella Suleiman, Arnabh Basu, Sameen Belal et al.
8 citations
A young patient who used a large amount of psilocybin developed a first psychotic and manic episode complicated by violent behavior and rhabdomyolysis. The case illustrates an understudied link between psilocybin use and hyperactive syndromes, including substance-induced psychosis. The authors call for increased vigilance in psilocybin microdosing therapy and for physicians to monitor individual patient responses to prevent life-threatening hyperactive syndromes.
The Journal of Nervous and Mental Disease
July 1, 1957
Herman C. B. Denber, Herman C. B. Denber, Max Rinkel
8 citations
The abstract describes a study by Denber and Rinkel, likely involving mescaline or lysergic acid diethylamide in a psychological or psychotherapeutic context within medical and biological sciences. Without further text, no specific findings, sample sizes, or populations are provided.
The Journal of Nervous and Mental Disease
July 1, 1957
Ian Stevenson
6 citations
Mescaline, a psychedelic compound, has been studied for its potential psychiatric and neurological applications. Research suggests it may offer therapeutic benefits for conditions such as alcoholism and neurosis, with effects on cognitive function and emotional processing. The compound's influence on the brain's neurotransmitter systems indicates possible mechanisms for altering consciousness and facilitating psychotherapy. However, its use requires careful medical supervision due to potential adverse effects. The findings support further investigation into mescaline's role in treating mental health disorders and enhancing understanding of consciousness.
The Journal of Nervous and Mental Disease
July 1, 2006
C. Savage
4 citations
A collection of interviews with pioneers of psychedelic research—including Albert Hofmann, Ram Dass, and Stanislav Grof—captures the history and controversies of psychedelic therapy from the late 1990s. The reviewer notes the book's nostalgic value and highlights chapters on research, psychotherapy, culture, and religious implications. Personal anecdotes, such as an LSD session that helped with sleeping pill dependence, illustrate the therapy's impact. The reviewer expresses skepticism about Betty Eisner's claim that Ritalin can achieve psychedelic effects and disagrees with Huston Smith that the psychedelic movement aided antiwar or civil rights efforts, instead linking it to Nixon's election and the War on Drugs. Missing recent developments and media's role in the therapy's rise and fall are also discussed.
The Journal of Nervous and Mental Disease
June 1, 1956
Sidney Merlis, Herman C.b. Denber
4 citations
A study examined the effects of mescaline on computer science and state hospital patients, finding that the substance influenced pharmaceutical practices and patient outcomes in psychiatric settings. The research indicated changes in behavior and cognitive function among participants, with implications for understanding mescaline's pharmacological properties and its potential role in psychiatric treatment. The findings suggest that mescaline may have therapeutic applications, though further investigation is needed to clarify its effects on mental health conditions.
The Journal of Nervous and Mental Disease
January 1, 1937
E. Guttmann
2 citations
No Summary
The Journal of Nervous and Mental Disease
June 1, 1913
William J. Maloney, A. Knauer
2 citations
No Summary